Immusoft
Immusoft develops cell therapies that program patients’ own B cells to produce therapeutic proteins for sustained delivery. Its therapies are intended for people with rare and other diseases with significant unmet need.
Facts
- HQ
- Seattle
- Sectors
- Biotechnology Research
- Founded
- 2009
- Type
- Corporation Seattle business license
- Employees
- 21
- Registered name
- Immusoft Corp Seattle business license
- Stage
- Series B
- Members see funding amounts. .
- Founders
- Matthew Scholz
Is this your organization? Claim it
Executives
-
Sean Ainsworth Executive, Executive Officer, Director, Chief Executive Officer
-
Scott McIvor Executive, Chief Development Officer